Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
absolute, aggressive, Alfasigma, Alicia, AMAG, Anderson, Appendix, Arizona, ascertain, ballistic, Banatrol, behavior, bi, bleeding, blended, bond, bovine, breadth, bribery, brochure, budesonide, Cadila, carryback, Circle, citric, Clal, Clenpiq, Clostridium, Cohen, comercial, compassionate, compromise, compromised, concentration, concomitant, Concrete, conducive, constraint, Crit, crossover, CSR, Culturelle, Cusso, customer, cyber, cyclosporine, decentralized, Deloitte, denial, Dexilant, dexlansoprazole, dietary, diff, difficile, diminished, disgorgement, distinctive, distraction, dominant, duct, EAP, eating, electrical, electrocardiogram, encrypted, Eng, Entera, EnteraGam, enteropathy, entrance, erode, erosive, error, esomeprazole, essential, Euro, eventual, exhausted, exit, explicitly, extrahepatic, fatigue, FCPA, FDCA, feeding, female, fired, flu, footnote, Foster, Gastroenterol, gastroenterologist, gastroesophageal, geographic, geopolitical, GERD, GJ, GLOBOCAN, Gold, HC, HealthScience, Heidelberg, HIPAA, hypersecretory, IBD, IBGard, imprisonment, improper, inappropriate, Incomplete, input, inside, intercompany, intermediate, Internet, intrahepatic, intrusion, inventory, isolate, Katz, lansoprazole, largest, Lauridsen, lawfully, lethal, likewise, literature, Lomotil, loose, loperamide, LS, lung, MAC, male, malfeasance, malware, maturity, maya, Mayo, meal, Med, Medtrition, metabolite, microbial, militant, mobile, Modulen, mofetil, Motofen, movement, mucoadhesive, Mugard, multitude, mycophenolate, Mytesi, Napo, nasogastric, Nestle, Nexium, NG, NOL, notification, Nozia, nutritional, OTC, overdue, overt, parapro, PCAOB, penalty, peptide, perihilar, pharmacy, PhRMA, potency, potent, PP, PPI, pre, preempted, premarket, Prevacid, Prilosec, privacy, proactively, probiotic, pulmonary, qualitative, quantitative, Raleigh, ransomware, recite, Reclassified, reflux, reliant, Respir, restated, reward, robust, Rosenblatt, routinely, Ryu, SBI, serine, Sharon, shortened, Silver, simple, software, Soligenix, sophistication, spectrum, sphingolipid, stipulated, stolen, store, stored, strontium, supervisory, Symphony, symptom, synthesizing, synthetic, TALICIA, telecommunication, tenant, terrorism, Tolerex, transmission, tube, Tuberc, UltraInflamX, undesirable, unique, upset, URL, USA, Valle, vitro, Vol, vulnerable, worse, worst, XBRL, YJ
Removed:
absorbed, accrual, addressed, Agrea, agree, Aharon, Alterpharma, amounted, article, aura, BDO, belong, BfArM, binding, blind, bloodstream, bone, buyer, carriage, centralised, clofazamine, combine, compare, constrict, Construction, conventional, corrective, CRL, crystalline, cytotoxic, Dana, decentralised, discrete, disrupted, dissolve, dissolving, Dohme, domestically, duration, ease, Egypt, ending, equivalence, Ernst, escalation, evacuant, exacerbation, exclusively, exhibiting, facility, favorably, feature, film, formula, frequency, frequent, Germany, GlaxoSmithKline, gmbh, Haft, Hananel, Imitrex, importing, indefinite, Industrial, intern, internationally, invited, involvement, Kidron, Lezion, lingua, Lipton, Luxembourg, Maxalt, Merck, methylhydroxyalkylcellulose, MLT, moderately, monoclonal, mouth, MSD, mucosa, older, overcome, overgrowth, phenylalanine, portability, PrevPac, producing, Pylera, reimbursing, responded, RESprotect, resumption, RHB, Rishon, rizatriptan, sending, Sharp, soluble, Specification, stem, stepping, straight, struggle, sumatriptan, supervising, suppository, swallowing, swelling, thin, triptan, unaffordable, unavailable, unlimited, uPA, Uri, urokinase, VersaFilm, VersaFilmTM, vis, Visicol, western, Young, Ziv, zolmitriptan
Filing tables
Filing exhibits
RDHL similar filings
Filing view
External links
Exhibit 13
CERTIFICATION BY CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUAN TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of RedHill Biopharma Ltd. (the “Company”) on Form 20-F for the period ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to such officer's knowledge:
(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: February 21, 2018 |
|
|
|
/s/ Dror Ben-Asher |
|
Dror Ben-Asher |
|
Chief Executive Officer |
|
|
|
/s/ Micha Ben Chorin |
|
Micha Ben Chorin |
|
Chief Financial Officer |
|